Exabis Library
Welcome to the e-CCO Library!
P291: Effect of the preconception steroid-free remission period on disease activity during pregnancy and birth outcomes in women with Ulcerative Colitis: a retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P291: Improvements in access to IBD care following the implementation of a novel tiered triage model
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P291: Long term outcomes of children with ulcerative colitis after acute severe colitis: a multicenter study from the GETAID pédiatrique group
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P291: Pharmacokinetics, safety, and tolerability of etrasimod (APD334) in subjects with mild, moderate, or severe hepatic impairment: a single-dose, open-label, parallel-group study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P291: Proteinase 3-antineutrophil cytoplasmic antibodies (PR3-ANCA) would be a predictive biomarker for the clinical course of ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P291: Sacroiliitis is under-recognised in inflammatory bowel disease and is associated with previous arthritis and inflammatory Crohn’s phenotype
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P292 Inflammatory bowel disease and their implications in Roma ethnicity: A preliminary study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P292: Association of golimumab trough concentrations during maintenance with endoscopic and histologic remission in patients with ulcerative colitis.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P292: Complications in elderly-onset Inflammatory Bowel Diseases – A population-based study from the epidemiological database of the Israeli IBD Research Nucleus (Epi-IIRN)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P292: Development of a predictive model for the diagnosis of Crohn’s disease when ileocolonoscopy is insufficient: a multicentre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P292: Effect of drug therapy on the lipid profiles of patient with Inflammatory Bowel Disease: a systematic review and meta-analysis
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P292: Faecal calprotecin may be a good predictor of histologic remission in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P292: Immunomodulator and biological therapy are increased in inflammatory bowel disease patients with associated immune-mediated inflammatory diseases
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P292: Perianal disease: far beyond a simple feature of Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P293 Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P293: Correlation between clinical measures to capture disease burden and prediction of the initial course of Crohn's disease - findings from a Copenhagen IBD Inception Cohort Study (IBD Prognosis Study)
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P293: Delayed timing of post-operative colonoscopy within 1 year does not predict a more severe Rutgeerts score
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P293: Histological risk factors to predict clinical relapse in ulcerative colitis in mucosal healing
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P293: Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P293: Insights from patients with Ulcerative Colitis on disease burden: Findings from a real-world survey in Europe
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM